Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2026-04-03 17:00:07 ET · period of report 2026-04-02 · accession 0001873796-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-03 17:00 | 2026-04-02 | CAPR | Sabar Karimah Es | Dir | M - OptEx | $3.18 | +7,529 | 7,529 | New | +$23.9K |
| DT | 2026-04-03 17:00 | 2026-04-02 | CAPR | Sabar Karimah Es | Dir | S - Sale+OE | $32.00 | -7,529 | 0 | -100% | -$240.9K |
| DT | 2026-04-03 17:00 | 2026-04-02 | CAPR | Sabar Karimah Es | Dir | M - OptEx | $0.00 | -7,529 | 161 | -98% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-02 | M | A | 7,529 | $3.18 | 7,529 | D | — | — | |
| 2 | Common | Common Stock | 2026-04-02 | S | D | 7,529 | $32.00 | 0 | D | — | — | (F1) Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-04-02 | M | D | 7,529 | $0.00 | 161 | D | $3.18 · — to 2032-01-03 | 7,529 Common Stock | (F2) Shares vested 1/48th on the first day of each month commencing February 1, 2022. |